Is your primary class' spelling word practice fun and engaging? Do your students ask to practice their spelling words AGAIN?To be completely honest, spelling word practice used to be boring in my classroom. It took up too much time and my kiddos just didn't like it. Literacy is so important, and I want my students to love words.So I put on my thinking cap and cracked the spelling word practice code. Now I have a routine that is highly engaging, fun, and super easy to use every day. Sound too good to be true? I promise you, it's not. My students ask me regularly to practice their spelling words because they enjoy the routine that much. If it can work on my kiddos, I know it can work for yours too.Links in today's episode: Today's blog postPhast PhonicsEpisode 69 - character pointsGrowing Beat the ____ Bundle
https://youtu.be/nvzjyJuXqy0 It was Stalin who had invaded six western neighbors between 1939 and 1941, alarming the Germans and other neighbors who were afraid of being devoured next. The Soviet invasions of Finland and Romania had backfired spectacularly, as these countries were now fighting alongside the German Wehrmacht to redeem their honor and regain their lost territory. Sean McMeekin, Ph.D., Stalin's War: A New History of World War Two (Basic Books, 2021) p. 261 Sean McMeekin, Ph.D., is a professor of history at Bard College. The award-winning author of several books, including The Russian Revolution, July 1914, and The Ottoman Endgame, McMeekin lives in Clermont, New York. Buy Stalin's War: A New History of World War Two: https://www.basicbooks.com/titles/sean-mcmeekin/stalins-war/9781541672796/ Odysee BitChute Minds Flote Archive Spotify
Marc-André Argentino discusses the challenges of collecting, curating, and analyzing primary material from extremist spaces. The interview today was conducted by Sina Kashefipour and show is produced by Chelsea Daymon and Sina Kashefipour. If you have enjoyed listening to The Loopcast please consider making a donation to the show through our Patreon. We greatly appreciate it.
If your child escalates quickly, struggles to calm down, and hates talking about their feelings… there's nothing wrong with them. And there's nothing wrong with you. Your kid is probably a Deeply Feeling Kid. In this week's episode, Dr. Becky hears from three parents of DFKs and explains why these kids need a different approach—and what that approach looks like. She shares scripts and strategies to help you show up as a sturdy leader, put up boundaries to stop difficult behavior, and bring out the good inside your child. Dr. Becky also reminds parents that seeking additional support for your DFK is a sign of everything that's *right* in your family: You're willing to work through the tricky things, together. Follow Dr. Becky on Instagram: https://www.instagram.com/drbeckyatgoodinside/ Subscribe for weekly strategies and scripts:https://goodinside.com/newsletter/ Learn more with Dr. Becky's workshops: https://learning.goodinside.com/ Today's episode is brought to you by the following sponsors: The team at Primary. Check out the wide range of options at www.primary.com and get 20% off your first order with code GOODINSIDE. Rent The Runway. Check out Rent The Runway's monthly membership at www.renttherunway.com and get 40% off with code GOODINSIDE.
I’ve been posting on why Redemption Hill Church is confessional. The term confessional has lost its luster over the last 100 years, but prior, most churches held to a Confession of Faith. In this series of blog posts, I want to show the value of confessions and why a local church should be confessional. The series on confessionalism is about 1) The Nature of Confessionalism, 2) The Parameters of Confessionalism, 3) A Vision of Confessionalism 4) the Subscription to a Confession. If you are new to confessionalism, or the term is foreign, that’s ok. The purpose of cornfieldtheology.com is to introduce people to new concepts, terms, and theological ideas. These four blog posts on confessionalism have been adapted from a paper I submitted to the elders of Trinity Fellowship Churches in preparation for Theology Day before our General Assembly in November of 2021. In this second of four posts, I discuss the parameters of a Confession of Faith. I’ll state the purpose of this post with a question: how much theology should, or should not be, in a Confession of Faith? Somewhere In The Middle A Confession of Faith is not a systematic theology book. A systematic theology book has its place, but it is not a functional expression of faith for a local church. In 2020 I took several members of the church through a systematic theology book. The class enriched the students. It provoked good questions. But there was a sense that the breadth of a systematic theology book can be overwhelming. A person could study systematic theology for a lifetime and die realizing they have only scratched the surface. And there is the other end of the spectrum. A Confession of Faith cannot be summed up in a few statements on a church website. Try this for an exercise. Contact your local pastor and ask how he decided what ten theological points to put on the website? Did he copy and paste from another website? Is the statement of faith so vague that a Catholic, Presbyterian, Baptist, and Methodist all agree? Far too many local churches, networks, and denominations refuse to be held accountable with “all that theology.” To take the words of Alexander Hamilton out of context, “If you don’t stand for something, you will fall for anything.” So, if a Confession of Faith is not taking a seminary class on systematic theology, and it’s not your garden variety 10 points found at a local church website, then what is the right balance for a Confession of Faith? A Confession of Faith aims for the middle. It is deep in its theology and wide in the various doctrines. A Confession of Faith cannot address everything, but it addresses much. A confession must have primary doctrine and secondary doctrines. Tertiary doctrines should be held with an open hand and often not included in a Confession of Faith. Primary doctrines include doctrines central to the gospel of Jesus Christ. For example, the incarnation, atonement, and justification must be affirmed, taught, and defended at all costs. Secondary doctrines are also essential and help to distinguish a church or denomination from other churches and denominations. Secondary doctrines might include baptism, the Lord’s Table, and the revelatory gifts of the Holy Spirit. Tertiary doctrines are not a point of division and distinction but are no less worthy of time, study, reflection, and conviction. A tertiary doctrine might include the specifics of eschatology. There is no need to break fellowship with a brother or sister in Christ who holds to historic premillennialism when I hold to reformed amillennialism. The challenge lies in determining what is primary, secondary, and tertiary. Primary doctrines are more obvious, but secondary and tertiary doctrines might be malleable d
An award-winning author and podcaster, Carmela Ramaglia teaches women how to ditch the diet drama and create a body AND life they love. She earned her PhD in personal transformation with an emphasis in body image, self-esteem and weight loss from the very prestigious School of Hard Knocks. Her signature Model of Alignment and “Happy Calories Don't Count” Method have helped women from all across the world find freedom from food and body shame while optimizing physical results. Carmela is also a classically trained Pilates instructor, actress and model. She has heard in more than one check-out line, “Didn't I see you on TV?” When not working, Carmela can be found rocking out 80s Hair Bands, loving on her fur babies and hanging out with her family. Find Carmela here: Websites: www.carmelaramaglia.com (Primary) - Free Master Class Opt-In, Free Love Notes Opt-In www.happycalories.com (Coaching) www.foodisnotafourletterword.com (Podcast) Facebook: https://www.facebook.com/groups/BodyBreakthroughAndBeyond/ - Private group offering support https://www.facebook.com/HappyCaloriesDontCount/ https://www.facebook.com/FoodIsNotAFourLetterWord/ (New page - specific to the book) IG: https://www.instagram.com/thecarmelaramaglia/ (Primary) https://www.instagram.com/happy.calories.dont.count/ https://www.instagram.com/food.is.not.a.four.letter.word/ (Specific to the book) YouTube: https://www.youtube.com/HappyCalories Podcast: Available on All Major Platforms, YouTube Channel and www.foodisnotafourletterword.com website ------ About Erin Keam Erin Keam is a Kiwi living in Seattle who works with women solopreneurs to create their ideal life and achieve their vision. She combines her 23 years' experience mentoring and being mentored in the recovery field with her career in marketing, film, media, TV, advertising, real estate and customer service (and a passion for fashion) to be a trusted source for solutions to what is getting between you and the life you want. She offers two paths to progress. One is her unique LifeStyle Statement sessions, in which women uncover their personal themes which are distilled into a one-of-a-kind Statement which can then be taken to every area of their life from wardrobe to relationships to their business to their career and their home. The other are her “pressure relief” mini-intensives where the focus is on moving closer to your vision through exploring and tackling personal and marketing issues which are keeping you stuck, whether clarifying your website's message to your clients, looking at how you spend your time and money, decluttering (mental and physical), dressing as who you want to be, assessing the first impression your media and home office make on your ideal clients and creating action plans to get you the life you want. When she's not doing this, she's interviewing women entrepreneurs on her podcast Conversations About Closets With My Closet 1000 Friends, about what they do, why and what they love about it, with one or two questions in there about clothing (there's that passion for fashion!). Female-identifying (or non-binary) and want to be a guest? Book here! You can find out more on her website erinkeam.comShe would love to connect with you on Instagram or LinkedIn or Facebook. Hey, Koa Club members! Something getting between you and your goals? Often, all we need is someone to hold space while we talk through what's keeping us stuck and the solution presents itself. Book a Talk it Out Call here with Erin. If you want an action step, she'll suggest one. --- Support this podcast: https://anchor.fm/erin-keam/support
During the 2008 recession, David Kislin's bank that handled his construction loan filed for bankruptcy. Fearful for the future, his partners backed out of the project, causing David to lose half of his equity on the deal, totaling around $6 million. From lessons learned on relying too much on investors to the time saved on more granular deals, today David shares why he believes smaller deals can be smarter deals. David Kislin Real Estate Background Full time commercial real estate investor since 1999 Primary focus in multifamily, select commercial properties, and land for ground-up development using a mix of personal capital and a small group of high net worth investors Current portfolio consists of over $300M properties completed Based in Boca Raton, FL Say hi to him at: https://jeldevelopment.com/ Click here to know more about our sponsors: Deal Maker Mentoring | PassiveInvesting.com | FollowUp Boss
Let's talk about five primary emotions: joy, fear, anger, sadness, shame, and disgust – feeling all of them is important, especially with your partner. Emotions are the language of the body. They say, "pay attention, something's happening!" But so often we don't pay attention, choosing, consciously or unconsciously, to disconnect... We may have been raised in homes where anger was expressed in an unhealthy way, joy covered by a wet blanket, or shame used to control and manipulate our behavior. Regardless of how our childhoods taught us to relate to emotions, we can rewrite the script by creating healthy emotional attachments and responses. While there are many tools we can use to do that, in this episode we're going to talk about co-regulation and co-creation ("CoCo.") And learn how to share and navigate emotions together. If your loved one is excited, you match their excitement. If your loved one is angry, you honor their anger. Co-regulation is not co-dependency. Co-regulation does not say, "I feel happy only if you're happy." It says, "You feel happy, and I'm happy for you." Co-regulation allows the witness to be there for their partner while also honoring their own emotions. Most of the time, people don't understand the emotion they're in, and they need someone to support them in a curious and non-judgemental way. Co-creation allows partners to act as witnesses for each other. By asking questions and being present, the witness can help the emoter explore and deepen their understanding of their feelings. Listen to learn how to apply 'CoCo' to your relationship and create positive shifts in your emotional and sexual cycles!
Teacher, are you losing time and maybe a little sanity every time your primary students have to transition from one activity to another?It's no secret that I love classroom management, and this is an area that is often noticed during observations. People are amazed by how well my students transition and how little time they take to do it.Today, I'm going to share five tips for seamless classroom transitions so you can make every second count in your classroom.Links mentioned in today's episode:Today's blog postEpisode 67 - about my coachEpisode 68 - Tiny Human Tamer episodeTop Secret Classroom Management Tricks videoCheer Cards
Sydney E. Schultz, PharmD identifies signs, symptoms, and diagnostic criteria for multiple myeloma, reviews pharmacology of medications used as primary treatment for multiple myeloma and discusses recent literature regarding four-drug regimens. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Let's talk about some of the best world drop weapons! 13:49 - Annual Skate 29:08 - Legal Action II 44:46 - Contingency Plan 56:42 - Shepherd's Watch 1:04:45 - Cartesian Coordinate
When former NFL tight end Greg Olsen and his wife Kara's son TJ was born with a congenital heart defect, they had no idea what to expect. Their parenting journey has since been defined by countless hospital visits and numerous surgeries, but it has also been defined by hope and resilience. In this week's episode, the couple talks with Dr. Becky about how navigating their child's major medical issue has shaped them as parents, partners, and people. They share how to mentally prepare your child (and yourself) for unknowns, why “small wins'' keep them going, and how they've witnessed TJ and their other two children, Tate and Talbot, embody resilience. You can learn more about Greg and Kara's work supporting other families navigating pediatric heart disease through their Heartest Yard Foundation and newest charitable effort, Receiving Hope, at www.r4r.org A preview of the good inside this episode: (1:44-6:46): Family transitions while learning about son's heart failure (6:47-11:00): Emotional preparation through honest communication (11:01-16:28): The power of positivity and naming what you don't know (16:29-21:07): Life after recovery in the time of Covid (21:08-26:15): Managing life and emotions as a family leader (26:16-32:19): Balancing being parents of three (32:21-36:09): Building the HEARTest Yard Foundation (36:10-39:32): Lessons learned (39:38-40:34): Closing Remarks Today's episode is brought to you by the following sponsors: The team at Primary. Check out the wide range of options at www.primary.com and get 20% off your first order with code GOODINSIDE. Rent The Runway. Check out Rent The Runway's monthly membership at www.renttherunway.com and get 40% off with code GOODINSIDE.
Sean Illing talks with Briahna Joy Gray, the former national press secretary for the Bernie Sanders 2020 Presidential campaign, and current host of the Bad Faith podcast. They discuss the practical challenges facing the Left in the Biden era, untangle the ways in which race and class affect electoral outcomes and should influence messaging strategies, and assess the state of the ongoing effort for a platform of robust, material economic changes. Host: Sean Illing (@seanilling), Interviews Writer, Vox Guest: Briahna Joy Gray (@briebriejoy), Host, Bad Faith podcast References: "Looking for Obama's hidden hand in candidates coalescing around Biden" by Carol E. Lee, Kristen Welker, Josh Lederman and Amanda Golden (NBC News; Mar. 2, 2020) "'Accelerate the Endgame': Obama's Role in Wrapping Up the Primary" by Glenn Thrush (New York Times; Apr. 14, 2020) "Race and Realignments In Recent American Elections" by Michael Barber and Jeremy C. Pope (working paper; Nov. 8) "Commonsense Solidarity: How a working-class coalition can be built, and maintained" by Jared Abbott, Leanne Fan, et al. (Jacobin & Center for Working-Class Politics; Nov. 2021) Bad Faith, ep. 117: "Are Progressive Policies Really Popular? w/ Matt Bruenig, Eric Levitz, & Osita Nwanevu" (YouTube; Oct. 22) "A Problem for Kamala Harris: Can a Prosecutor Become President in the Age of Black Lives Matter?" by Briahna Joy Gray (The Intercept; Jan. 20, 2019) "How Barack Obama helped convince NBA players to end their strike and return to play" by Ricky O'Donnell (SB Nation; Aug. 29, 2020) White Fragility by Robin DiAngelo (Beacon; 2020) Why I Am Not a Feminist: A Feminist Manifesto by Jessa Crispin (Melville House; 2017) Enjoyed this episode? Rate Vox Conversations ⭐⭐⭐⭐⭐ and leave a review on Apple Podcasts. Subscribe for free. Be the first to hear the next episode of Vox Conversations by subscribing in your favorite podcast app. Support Vox Conversations by making a financial contribution to Vox! bit.ly/givepodcasts This episode was made by: Producer: Erikk Geannikis Editor: Amy Drozdowska Engineer: Paul Robert Mounsey Deputy Editorial Director, Vox Talk: Amber Hall Vox Audio Fellow: Victoria Dominguez Learn more about your ad choices. Visit podcastchoices.com/adchoices
Primary care in the UK is in crisis. General practice was already under huge strain, as a result of the pandemic, high levels of seasonal respiratory viruses, as well as chronic understaffing and underfunding, but recent negative media campaigns against GPs, amidst the health secretary's plans to publish ‘league tables' of GP practices, have added to this and have led to increased demoralisation among doctors. In this week's episode, we discuss the current political climate affecting the NHS, perceptions of our healthcare system, and how this has changed over the last 10-20 years. If GP ‘league tables' are not the answer, what creative solutions are needed in order to encourage new GPs into primary care, and to retain doctors in the workforce? Our guests: Gareth Iacobucci is the assistant news editor for ‘The BMJ'. Lucy Martin is a GP, working in Dudley, as well as the acting medical director for Dudley Integrated Health & Care NHS Trust.
The affections of our hearts are central to true worship. Yet while praise, joy, contrition, and love are all important affections for worship, I believe gratitude is the most important worship affection. Listen as Scott Aniol explains. Read this post here: https://g3min.org/thanksgiving-the-primary-worship-response --- Support this podcast: https://anchor.fm/scottaniol/support
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-251 Overview: Primary care providers should be up to date on the changes to the guidelines for cervical cancer screening to be able to guide patients in shared decision-making about health maintenance. Join us to review the recent changes to cervical cancer screening guidelines as recommended by the American Cancer Society. Episode resource links: Cervical Cancer Screening: Updated Guidelines from the American Cancer Society. Am Fam Physician. 2021 Sep; 104(2):314-315. American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. Practice advisory. April 2021. Accessed September 30, 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines Fontham, ETH, Wolf, AMD, Church, TR, et al. Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society. CA Cancer J Clin. 2020. https://doi.org/10.3322/caac.21628. Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato
#20, No Nonsense November 2021! Power Of Questions...Your Primary Question? Pop in Every Morning for lessonsl eearned from decades of business and life lessons!: https://facebook.com/getupandgochallenge For all the insider perks (Recordings Always Available...no disappearing content), make sure you join the FREE Facebook Group Here: https://facebook.com/groups/getupandgochallenge #nononsensenovember #guaranteedresults #powerofquestions
Ohio Representative, Bride Rose Sweeney, of Cleveland discusses her background, legislative approach and important current initiatives. Biography and Legislation | Facebook | Twitter134th General Assembly Committee AssignmentsFinanceFinance Subcommittee on Primary and Secondary EducationFinancial InstitutionsInsurance
On Episode 10 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the November 2021 issue of Stroke: “Biomarkers of Coagulation and Inflammation in COVID-19–Associated Ischemic Stroke” and “Treatment-Associated Stroke in Patients Undergoing Endovascular Therapy in the ARUBA Trial.” She also interviews Dr. S. Claiborne Johnston about “Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.” Dr. Negar Asdaghi: 1) What is the net ischemic benefit derived from combination of ticagrelor and aspirin treatment in patients with mild ischemic stroke or transient ischemic attack? 2) Is the ischemic stroke in patients hospitalized with COVID-19 associated with the rise in biomarkers of inflammation and coagulopathy? 3) What are the characteristics associated with periprocedural stroke in patients treated endovascularly for an unruptured AVM? We'll discuss these topics and much more at today's podcast. Stay with us. Dr. Negar Asdaghi: Welcome back to the Stroke Alert Podcast. My name is Negar Asdaghi. I'm an Associate Professor of Neurology at the University of Miami Miller School of Medicine and your host for the monthly Stroke Alert Podcast. For the November 2021 issue of Stroke, we have a large selection of topics, from peanut consumption reducing the risk of ischemic stroke, and the decline in the rate of progression of coronary atherosclerosis in patients on a Mediterranean diet, to how the efficacy of endovascular thrombectomy diminishes in patients with more pervious thrombus composition, which I encourage you to review in addition to our podcast today. Dr. Negar Asdaghi: Later in the podcast, I have the distinct honor of interviewing Dr. Claiborne Johnston from Dell Medical School at UT Austin on his latest work with data from the THALES trial to clarify the net ischemic benefits derived from a combination of ticagrelor and aspirin therapy in comparison with the risks of hemorrhage associated with this treatment in patients with mild and moderate stroke and TIA. But first with these two articles. Dr. Negar Asdaghi: COVID-19–associated ischemic stroke, or CAIS, is a new term that, unfortunately, stroke physicians need to be familiar with. While acute ischemic stroke can occur in parallel from, say, traditional causes of stroke in patients infected with coronavirus, ischemic stroke and other thrombotic events, such as myocardial infarction, pulmonary embolism, deep vein thrombosis, and acute limb thrombosis, can occur in the setting of overt hyperinflammation and subsequent coagulopathy that is observed in patients hospitalized with severe COVID-19 illness. Dr. Negar Asdaghi: Elevated D-dimer, although quite non-specific, has emerged as a marker of COVID-19–associated coagulopathy, but whether an elevated D-dimer in isolation or in combination with various other inflammatory and coagulation markers is associated with development of acute in-hospital ischemic stroke in those hospitalized with COVID is not known. Dr. Negar Asdaghi: So, in the current issue of the journal, in the article titled "Biomarkers of Coagulation and Inflammation in COVID-19–Associated Ischemic Stroke,” Dr. Charles Esenwa from the Department of Neurology at Montefiore Medical Center and colleagues did an interesting analysis of over 5,000 patients with COVID-19 who were admitted to one of the Montefiore Health System hospitals between March 1, 2020 and May 8, 2020. This was a retrospective analysis, so they had to work with the available biomarkers for each patient and use a machine learning cluster analysis of these biomarkers to divide the patients basically based on five biomarkers to four clusters. Dr. Negar Asdaghi: The following five biomarkers were chosen by this machine learning cluster analysis. These included CRP, D-dimer, LDH, white BC, and PTT. So, they had to come up with some arbitrary rules to exclude biomarkers that were either missing in over 30% of their population, and they also excluded those patients that were hospitalized for a long period of time, and they chose a 30-day hospitalization and over. And they also only used the first reading for each biomarker. Again, these were arbitrary rules that were set forth by the authors, and they found some alarming findings. When they clustered patients based on similarities in these biomarkers, they came up with predicted models for combined thrombotic events and acute ischemic stroke. Dr. Negar Asdaghi: For example, in the cluster where the patients had the highest mean values for CRP, D-dimer, LDH, and white BC, and a relatively low PTT, these patients had the highest prevalence of acute ischemic stroke. They had the highest prevalence of in-hospital strokes and severe strokes and highest percentage of total thrombotic events. In contrast, the cluster with the lowest mean of all of these five biomarkers had no cases of in-hospital acute ischemic strokes; they had the lowest prevalence of composite, all thrombotic events, and patients had the least severe complications. Dr. Negar Asdaghi: So, they also tested the effects of biomarkers individually for prediction of acute ischemic stroke. And it turns out that when they used a lone marker, only D-dimer again was associated with acute ischemic stroke. Very interestingly, D-dimer was specifically elevated in those COVID-19 patients in whom the stroke was ultimately classified as cryptogenic. Dr. Negar Asdaghi: So, what does that mean? That means that it's more likely that a stroke had occurred in the setting of severe COVID-19 hyperinflammatory response, and less likely associated with other classical causes of stroke. Dr. Negar Asdaghi: So, what did we learn overall from this study? Well, hospitalized COVID-19 patients with a combination of high CRP, D-dimer, LDH, and white BC, and slight reduction in their PTT, had a 4.5-fold increase in the risk of in-hospital mortality and a fivefold increase in the risk of in-hospital stroke as compared to the COVID-19 patients with the lowest mean values for all the five biomarkers mentioned above. So, important information to keep in mind as we treat hospitalized COVID-19 patients, and we await more prospective data on this topic. Dr. Negar Asdaghi: Arteriovenous malformations, or AVMs, are congenital vascular lesions that are associated with long-term excess mortality and morbidity, essentially almost all related to their risk of intracerebral hemorrhage. Roughly half the patients with brain AVMs present with intracerebral hemorrhage, resulting in a first-ever hemorrhage rate of about 0.5 per 100,000 person years. Dr. Negar Asdaghi: Annual risk of hemorrhage is estimated at 1 to 4% for all comers with AVMs, but varies significantly, and can be as low as 0.9% in patients with unruptured, superficially located brain AVMs with superficial drainage, but may be as high as over 34% in patients with ruptured, deeply seated brain AVMs with deep venous drainage. So, treatment would entirely be dependent on the type of presentations and characteristics of each patient with an AVM. Dr. Negar Asdaghi: Whether unruptured AVMs should be managed clinically or treated either endovascularly or surgically is the subject of the ARUBA trial that is a randomized trial of unruptured brain AVMs. The enrollment of ARUBA was halted by the study's DSMB board, but medical management was found to be superior to treatment arm for the primary outcome of symptomatic stroke and death. Dr. Negar Asdaghi: Since then, there's been a lot of focus in the literature and comparison of outcomes between treated and untreated patients with unruptured AVMs, but less has been published on characteristics of patients who suffered from periprocedural stroke, an important part of the primary outcome of ARUBA. So, in the current issue of the journal, we have the study titled “Treatment-Associated Stroke in Patients Undergoing Endovascular Therapy in the ARUBA Trial.” Dr. Negar Asdaghi: Dr. Joshua Burks and colleagues from the Department of Neurosurgery at the University of Miami and colleagues evaluated 64 patients with unruptured AVMs enrolled in the ARUBA trial who underwent endovascular treatment as part of the trial and looked at the characteristics of those who suffered a perioperative stroke, defined as a stroke recorded at or within 48 hours of intervention, as this would represent a direct procedure-related complication rather than sequelae of, say, treated or partially treated AVM itself. Dr. Negar Asdaghi: All patients who initiated endovascular intervention, including attempted interventions in cases where therapy was aborted secondary to technical or anatomical limitations, were included regardless of randomization or subsequent withdrawal from the study beyond 48 hours following the intervention. So, what they found was that 16% of interventions resulted in stroke, 11% hemorrhagic, and 5% ischemic strokes. And they had no perioperative mortality, which is good news. Dr. Negar Asdaghi: In univariate analysis, they found many factors that were more commonly seen in patients that suffered from perioperative stroke as compared to those who did not have a stroke perioperatively. Those factors included, for instance, female sex. Over half of these patients were female. Close to half were enrolled in France. And over 40% of those who suffered a stroke in the perioperative timeframe had Spetzler-Martin grade two AVMs. Dr. Negar Asdaghi: When they accounted for all confounding variables, they found that endovascularly treated unruptured AVMs that are supplied by the posterior cerebral artery cortical feeders and those with Spetzler-Martin grade two and three had a higher perioperative stroke risk as compared to their counterparts without these characteristics. Interestingly, there are also significant geographical disparities in the risk of stroke in that patients treated in the United States or Germany had a significantly lower stroke risk than patients treated in other countries. Dr. Negar Asdaghi: So, what did we learn from this study? There are patients and lesion characteristics that increase the risk of stroke associated with endovascular treatment of unruptured AVMs. The current study suggests that AVMs with cortical arterial feeders from posterior cerebral artery and those with grade two and three Spetzler-Martin were associated with a higher risk of procedural and periprocedural stroke. Dr. Negar Asdaghi: And very importantly, as with every surgical intervention, the risk of a procedure is operator-dependent, as well as center-dependent. And these are important factors to keep in mind as technology evolves and more treatments become available to decide whether to keep or to refer patients with unruptured AVMs to a more experienced center. Dr. Negar Asdaghi: Patients with mild ischemic stroke and transient ischemic attack are at high risk of having recurrent ischemic events, especially in the immediate aftermath of their symptom onset. Early diagnosis and initiation of secondary preventive measures, such as antiplatelet or anticoagulation therapies, in the appropriate setting considerably reduce this recurrent risk. Dr. Negar Asdaghi: Multiple randomized trials have shown that as compared to treatment with a single antiplatelet agent, dual antiplatelet treatment is more effective in reducing the risk of stroke and other major vascular events in the TIA mild stroke population, a benefit that comes with an expected increase in the risk of hemorrhage. Dr. Negar Asdaghi: THALES trial is one of the latest trials to determine the efficacy of dual, which is combination of ticagrelor and aspirin, versus mono-antiplatelet therapy, that is aspirin alone, in eligible patients with non-cardioembolic acute ischemic stroke and TIA. Now, it's important to keep in mind that the primary outcome of THALES is a composite of stroke or death, which included both ischemic and hemorrhagic events. Dr. Negar Asdaghi: Now, it's important to understand that while in the setting of a clinical trial, combining the risks associated with dual antiplatelet therapy, which is hemorrhage, and the potential treatment benefit, that is reduction of recurrent ischemic events, is appropriate as part of the outcome selection. In routine practice, this type of primary outcome can obscure the actual trade-offs between the benefits of dual antiplatelet treatment and its inherent hemorrhagic risk. Dr. Negar Asdaghi: So, in this issue of the journal, in the study titled "Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack," the THALES investigators led by Dr. Claiborne Johnston sought to separate the ischemic benefits of combination of ticagrelor and aspirin therapy from its hemorrhagic risks in patients enrolled in the trial. Dr. Negar Asdaghi: I'm joined today by Professor Johnston to discuss the findings of this paper. Dr. Johnston absolutely needs no introduction to the stroke community and our readership. He's a Professor of Neurology at Dell Medical School at the University of Texas at Austin. He's a leader in the field of cerebrovascular disorders, has served as the primary investigator of multiple randomized trials and large prospective studies to evaluate the preventive treatment outcomes in TIA and mild stroke, and has pioneered the development and validation of predictive models for recurrent stroke in this population. He's authored over 700 peer-reviewed manuscripts, has won several awards for research and teaching, and is recognized for his leadership in the field of medicine and healthcare. Dr. Negar Asdaghi: Good morning, Clay. We're delighted that you could join us on the podcast. Dr. S. Claiborne Johnston: Well, thank you. It's wonderful to be here. Thank you for having me. Dr. Negar Asdaghi: Thank you. So, THALES is an exciting new addition to the most recent trials of dual antiplatelet therapy that studied mostly the role of clopidogrel and aspirin combination therapy. Can you please start us off by telling us why did we need a new trial in a very similar patient population? Dr. S. Claiborne Johnston: Well, the primary reason was, yes, clopidogrel works in combination with aspirin in the setting, but clopidogrel is actually a prodrug. It requires conversion in the liver to its active form. And polymorphisms in CYP2C19 and Cyt P450 pathways are really common and associated with an inability or limited ability to convert that prodrug into its active form. So, there are a number of people who may not benefit much, if at all, from clopidogrel. So, it's kind of surprising that it works as well as it does. Dr. S. Claiborne Johnston: Ticagrelor doesn't have that problem. It's not a prodrug. It acts directly on the P2Y12 inhibitor. And so, the hope was that we would have a more consistent and pronounced effect on risk reduction in patients after TIA and mild to moderate strokes. Dr. Negar Asdaghi: Primary efficacy outcome in THALES was different from the primary efficacy outcome chosen for the POINT trial, that was major ischemic events and death from ischemic vascular events, and that of the CHANCE trial, that was a combination of ischemic and hemorrhagic strokes in 90 days. Can you please tell us about the thought process behind choosing this particular primary efficacy outcome in THALES? Dr. S. Claiborne Johnston: Yeah, so this was encouraged by the regulatory authorities. And so the primary efficacy outcome in THALES is all stroke, hemorrhagic and ischemic, and all death, hemorrhagic and ischemic. And we teased apart just the ischemic etiologies in POINT. Dr. S. Claiborne Johnston: The rationale was that we were including all the major outcomes that the drug could impact. The problem is that people forget that it includes hemorrhagic events, and then they weigh that efficacy outcome against the safety outcome. And so there's confusion. There's sort of double-counting of safety elements in doing that comparison. Dr. Negar Asdaghi: Okay, great. And now, before we hear about how you disentangled the two safety and efficacy outcomes, can you please remind our listeners about the primary results of THALES, which was published obviously a few months ago? Dr. S. Claiborne Johnston: Yeah, sure. So, it showed that the combination of ticagrelor and aspirin works. It reduced the stroke and death by about 17% over the 30-day period of treatment. So robust effect. There were some increased hemorrhages, and looking at severe hemorrhage as defined by the GUSTO definition, there was almost a fourfold increase, but it was tiny in absolute terms of 0.4% increase. Dr. Negar Asdaghi: Okay. So, now it's very important, as you mentioned, this disentangling of recurrent ischemic, again, safety from efficacy outcomes. Your current study that is published in the November issue of Stroke clarified these results. And we're excited to hear about those results. Dr. S. Claiborne Johnston: That's right. So, there were two problems with the way people have interpreted the results of the THALES trial. One is this entanglement of safety events and both efficacy outcome and the safety outcome. The other was the use of relative risks as opposed to absolute risks, because a high relative risk for a rare event is less important than a small relative risk for a more difference between more common events. And so we wanted to deal with both of those issues. Dr. S. Claiborne Johnston: So, we defined new outcomes that were not entangled. So, we defined major ischemic events, similar to what we had done in POINT, and then we defined major hemorrhage as being basically irreversible hemorrhage, and compared outcomes in the two groups. And what we found was that when we did it that way, for every 1,000 patients treated, we avoided 12 major ischemic events and produced three major hemorrhages. So, about a four-to-one ratio of ischemic benefit to hemorrhage risk. And that was true at various cutpoints for disability. Dr. S. Claiborne Johnston: So, if we said, "Okay, yes, you had an event, and are you disabled at last follow-up at 30 days?" Then if we said that, there was also a four-to-one difference in disabling events, ischemic versus hemorrhagic. And if we said a two or greater, so moderate disability or worse, it was the same ratio, four-to-one. Dr. Negar Asdaghi: Okay, so four-to-one ratio of benefit. That's an important number to keep in mind. Also reassuring to see that this net clinical benefit or net clinical impact of the combination of therapy was practically the same across all the pre-specified subgroups in the trial. Were you at all surprised by the subgroup analysis? Dr. S. Claiborne Johnston: Well you know if you do enough subgroup analyses, you're going to find differences, right? And thankfully, we have the looking at interaction terms to keep us honest, but even so, you look at 20 and you're going to have some significant interaction terms, as well. But yeah, it was reassuring that the effects were so consistent across groups. Dr. S. Claiborne Johnston: I think there's been a tendency to over-interpret results from subgroup analyses. We don't have any evidence to suggest that we should be doing that here. I'm sure we can pick out groups that do better, and we've done that actually. The group with atherosclerosis does particularly well, but is that a chance event or is that real? I think we just have to be super-cautious about subgroup analyses. Dr. Negar Asdaghi: So, absolutely. One of the subgroups that I'm personally very interested in is just the time subgroup. So, all of the patients in THALES were enrolled within the first 24 hours, and the subgroup analysis did not show that there were any differences in terms of the net benefit between those that were enrolled earlier, within the first 12 hours, and those that were enrolled later, between 12 and 24 hours. But in routine clinical practice, we often see patients with TIA and mild stroke actually presented to us later than that timeframe entirely. Should we be giving them dual antiplatelet treatment? Dr. S. Claiborne Johnston: That's a great question. So, we did an analysis in POINT where we modeled out, would we still have an important significant net benefit if we had started the trial later? And we didn't start the trial later, right? So, this was just pretending like anybody who had an event early on was not in the study in starting at a later timepoint and modeling that out. And basically what we found was that for out to three days, there was still a benefit. And, in fact, if you look at that data and look at those tables, you could even say, even out to five days. Dr. S. Claiborne Johnston: I would say it's not unreasonable to do that given that the risks are so small and they're going to be even later with later treatment. But I would say, too, that even though we're not seeing greater impact within that first 24 hours versus 12 to 24, it just makes sense with event rates being as great as they are early on that if you don't treat with a preventive medication before an event occurs, it doesn't work. So, it just makes sense that as much as possible we ought to treat people as early as possible after their events. Dr. Negar Asdaghi: Very important findings and things to keep in mind. I want to ask you about the top two takeaway messages from the study. Dr. S. Claiborne Johnston: One is that there's a favorable benefit-to-risk ratio for ticagrelor/aspirin in mild to moderate actually ischemic stroke and high-risk TIA from THALES. So that would be number one. Dr. S. Claiborne Johnston: And then number two is watch your endpoints carefully. Think carefully, too, about whether balancing safety to efficacy events really makes sense and also whether focusing on relative risks really makes sense. I would encourage us, even though our journals tend to push us towards relative risks and we're more familiar with those, I'd encourage us to get more comfortable with using absolute risks in the way we look at data, but also in the way we talk to patients about their impact. Dr. Negar Asdaghi: Fair enough. I remember a few years ago, you visited us here at the University of Miami to deliver the annual Cerebrovascular Scheinberg Lecture. And you had mentioned that the idea of dual antiplatelet therapy treatment of patients with TIA mild stroke had come to you many years back when you were still in training, but it took many years for that idea to turn into reality, into randomized trials, and now translated into clinical practice. Dr. Negar Asdaghi: At the time, if you recall, this was right before you went to Europe to present the primary results of POINT at the European conference. And the trial results were not publicly available, so you were sworn to secrecy. You couldn't tell us about the results. It's been a few years since then. You've already completed yet another trial on this topic. Can I ask what's next for you and your team as it pertains to acute treatment of patients with TIA and mild stroke? Dr. S. Claiborne Johnston: Well, there are a few things. So, CHANCE-2 is a really interesting trial. My role in that was peripheral, just really advisory, but it's an exciting trial. So, basically it's looking at people with those CYP2C19 polymorphisms that I mentioned before, people who don't rapidly and readily convert clopidogrel to its active form, and randomizing them to clopidogrel versus ticagrelor. Dr. S. Claiborne Johnston: So, it's going to give us some head-to-head data on the two drugs and the people who may benefit the most from ticagrelor. And that is complete, and that will be published in the next few months. So, I that's going to be an important trial in people's thinking about how best to approach these patients. Dr. S. Claiborne Johnston: The second is, you know, we're not done. We still have a 5% risk of events, even in those three dual antiplatelet therapy. And so we need more agents. And we need to think about secondary prevention extending to other groups as well, just as you said, longer periods of time, more severe strokes, people after thrombolysis/thrombectomy. Those are big groups of patients at extreme risk for secondary events, and we have no agents and no data right now. Dr. S. Claiborne Johnston: I would be concerned about dual antiplatelet therapy in those patients, just given what we've seen about the risks of hemorrhage in the existing groups, which are again manageable and shouldn't change people's decision about treatment. But for the groups I just mentioned, risks of hemorrhage start to get greater. And so one worries about whether dual antiplatelet therapy's the right thing or whether other agents make more sense. So, yeah, we're interested in looking at other agents, some novel, for those other indications as well. Dr. Negar Asdaghi: Professor Johnston, thank you for your time, and we look forward to covering more of your research in the future. Dr. S. Claiborne Johnston: Well, thank you. It's been a pleasure. Dr. Negar Asdaghi: Thank you. Dr. Negar Asdaghi: And this concludes our podcast for the November 2021 issue of Stroke. Please be sure to check out the November table of contents for a full list of publications, including two important topical review articles, one on thrombus composition after thrombectomy, and one on pearls and pitfalls of perfusion imaging in acute ischemic stroke, as advanced neuroimaging continues to play a critical role in decision-making for acute stroke therapies. Dr. Negar Asdaghi: Now, speaking of advanced neuroimaging and the immense role that neuroimaging plays in our day-to-day practice, let's take a moment as we end our November podcast to remember how the concept of medical imaging first began over 120 years ago with the discovery of X-ray by German professor of physics Wilhelm Röntgen. Dr. Negar Asdaghi: On Friday, November 8, 1895, while experimenting with electricity, Röntgen accidentally discovered a new kind of rays that he referred to as X-rays. He soon realized that X-rays were capable of passing through most substances, including the soft tissues of the body, but left bones and metals visible. Dr. Negar Asdaghi: One of his earliest photographic plates of his experiments was a film of his wife Bertha's hand with her wedding ring clearly visible. This was the first time that the inside of human body was seen without performing surgery. Dr. Negar Asdaghi: From Röntgen's first X-ray image to the advanced neuroimaging that we review today on our portable devices, I can't help but wonder, what will your accidental discovery on a Friday fall afternoon in November do to advance the field of science and stroke 100 years from now, as we continue to stay alert with Stroke Alert. Dr. Negar Asdaghi: This program is copyright of the American Heart Association, 2021. The opinions expressed by speakers in this podcast are their own and not necessarily those of the editors or of the American Heart Association. For more, visit AHAjournals.org.
The first time I went to the circus, I was fascinated by the tiger tamer. He made it look so easy to keep a wild animal under control.Today, I want to tell you that you do something even more amazing every single day that you walk in your primary classroom. You are a tiny human tamer!Maybe you feel like what you do really isn't that special, but trust me, it is. Most people can't imagine being able to do what you do. We're humble around here, but today, I want you to realize that you are fantastic.Links in today's episode:Today's blog post3 Top Secret Classroom Management Tricks blog postEssentials for Student Engagement blog postJoyful Teacher Academy
It's Wednesday, which means #TheShot of #DigitalHealth Therapy day and in honor of the ongoing YourCoach.Health Global Coaching Symposium, Jim Joyce and I had the pleasure of chatting with self-described "38 year old kid that is just trying to figure it out" - Corey Dion Lewis (He/Him). Corey is a clinical #healthcoach and a fellow podcaster with a passion for The Healthy Project
158: Online Primary History Sources In this episode, you can learn why you would want to use online primary history sources as well as where you can find them. One use would be if your child is competing in National History Day which I talk about in episode 5. The 4 sources I mention are: […] The post Online Primary History Sources appeared first on Ultimate Homeschool Podcast Network.
Everyone talks about the “terrible twos,” but we rarely acknowledge the tricky twelve- to twenty-four-month stage. At one year, kids are rapidly developing: They're exploring the world, figuring out how to express their needs, and testing limits. It's messy, but here's the thing: The more prepared you are for this stage, the more grounded you can be in those messy moments. In this week's episode, Dr. Becky talks with three parents about the challenges of raising a one-year-old—from throwing food to throwing a tantrum. She emphasizes that our kids are not trying to irritate us, they're trying to learn, and shares practical strategies for helping them learn in a safe environment. A preview of the good inside this episode: (3:15-3:59): Why one-year-olds push boundaries (10:26-11:24): Tantrums aren't just normal, they're healthy (17:29:18:24): Meeting vs. seeing your child's needs (23:29-25:22): Three takeaways Follow Dr. Becky on Instagram: https://www.instagram.com/drbeckyatgoodinside/ Subscribe for weekly strategies and scripts:https://goodinside.com/newsletter/ Learn more with Dr. Becky's workshops: https://learning.goodinside.com/ This episode is brought to you by Vivvi. A company that's reinventing childcare and early learning for today's families. Visit www.vivvi.com and mention "Dr. Becky" to receive a free month at one of their campuses or a free week of at home childcare with any full-time enrollment. Today's episode is brought to you by the team at Primary. Check out the wide range of options at www.primary.com and get 20% off your first order with code GOODINSIDE.
On today's Locked On Giants podcast, host Ben Kaspick answers questions from listeners about the San Francisco Giants' 2021-22 offseason. Among the questions asked and answered are: Chances the team signs/trades for a veteran catcher vs. letting Joey Bart go in as their No. 1 choice for the catching position? Do you think Bart will actually start Opening Day? Or do you think the Giants will trade for the Yankees or Cubs starting catchers (Gary Sanchez, Willson Contreras), who only have one year remaining on their current contract, and have Bart No. 2 for the whole season and Curt Casali No. 3? Your thoughts on Brian Sabean vs. Farhan Zaidi after 3 seasons? Not results but more style, persona, media engagement, management style. What is the likelihood the Giants do at least one trade involving a mid-tier MLB player? They have a surplus of quality outfield prospects that should be attractive to many teams. Which current Giants pitching prospect has the best chance to make the starting rotation with an impressive spring training performance? Logan Webb extension: when? Do you like the Giants trading for someone like Jose Ramirez? Or is signing someone like Marcus Semien more likely? The Giants' offseason is going to be just as frustrating as the trade deadline, huh? Will they sign someone before December 1? Follow & Subscribe to the Locked On Giants Podcast on these platforms
Primary principals have been dealing with a number of sick leave applications from unvaccinated teachers wanting leave from today until the end of the year. The vaccine mandate is now in force and staff without their first jab are no longer allowed on school grounds. Principals Federation president Perry Rush told Morning Report a lot of teachers were missing out on money for their stance on vaccination. "They will have been stood away from that work and some will be on leave with pay, most will be on leave without pay."
If you want to be a UX researcher, you have to understand the difference between discovery, evaluative, primary, and secondary research. When Imani first became interested in UX research, she would hear evaluative and discovery research mentioned quite a bit and though she googled them to learn more about them, she didn't fully understand what they actually were, when to apply them, and which methods they encompassed until fairly recently. If you do some googling, you'll notice that there are different opinions among researchers as to which methods are evaluative and which are discovery. Since UX research is still a relatively new career path, it is actively being defined by those who are current practitioners. What constitutes primary and secondary research seems to be better understood and more universally defined. This episode unravels discovery, evaluative, primary, and secondary research. Support this podcast
As digital creators, naming our product is sometimes the last and hardest step of launching.Here’s a Magic Formula for naming any product…It’s with M.A.G.I.C.M - Make a Magnetic Reason Why ✨What’s the shorthand, juicy, sexy version of the RESULTS you can deliver with this product? Whenever you’re looking for a reason with your customers, always look for the emotional benefit. Tug at their heart or soothe the soul.And F*cking Sauce it up!Weight Loss = BELLY-SHREDDERReading Speed = MACH-ONE Page-FlipperA - Announce Your Avatar ✨Tell me who this is for and exclude everyone else. Your customers like being in a club all their own, and it makes copywriting SOOO much easier.Crank open that Marketing 102 textbook you had to buy for $450 to find some of those “marketing persona” names.Ex. Soccer Moms, Buff Nerds, IPA EnthusiastsG - Give Them a Goal ✨Your customers are on a journey. Your product is an accelerator to that journey. Now tell them where they’re headed when they use your product.The easy, obvious examples: Feel fit, Lose 10 Pounds, Earn More Income. You get it.I - Indicate A Time Interval ✨Much like in copywriting - time is on your side. Either add some urgency in your product’s name or turn time into your very own benefit.Ex. Earn 10X Income in 10 Days or LessC - Complete with a Container Word ✨Didn’t know what a container word was, but it’s essentially the tack-on word you use to make this product sound more than just a simple PDF or Zoom Link. Action words, bro.Ex. Blueprint, System, Masterclass, Challenge.Credit to Alex Hormozi (@alexhormozi) and his book $100M Offers - https://amzn.to/3C31f7wJordan P. AndersonP.S. - Did you know that you can directly reply to these emails? (All replies are privately sent to my inbox)📧 If you're a Gmail user, this newsletter may automatically get routed to your "Promotions" tab. To avoid this, just drag the newsletter to your "Primary" tab — and you'll never miss a post.100% Typo Guarantee —This message was made with love, not spellcheck. No English teachers were harmed in the making of this email. Subscribe at jordanpanderson.substack.com
Debbie G. owns up to her own stuff in a huge way in this episode. Along the way, we learn by-the-by that she and Joe Sliker eloped! They are now Mr. and Mrs. Sliker! Woo hoo! Congratulations to the newlyweds. And in the process the conversation leads to what makes a primary relationship. It's that it comes first. That's what makes it a primary relationship.
Today's episode is a special bonus one for those of you that have been dreaming of becoming a coach as I'm releasing a replay of my webinar with IIN's Jim Curtis. We're diving into the coaching industry, what it really takes to have a successful career as a coach, and how you can get started today. Time Stamps 4:40 Mel's coaching catalyst 10:55 There isn't “easy” without the hard 15:59 Living is giving 21:01 The importance of investing in yourself to grow 26:20 “Primary foods” – IIN Foundations 30:12 How to train yourself to heal yourself 34:34 The importance of learning in community 37:52 Taking the next step 46:00 Final advice from Mel Are you ready to answer the call to become a coach? IIN are currently running their biggest offer of the year where you can claim $2,500 OFF your tuition!! If you want to learn how to build impact and change lives with the world's leading certification school, get started today by using this link to enrol: https://bit.ly/3F1tghQ Mentioned in this episode: Click here to claim $2,500 off your Institute of Integrative Intuition tuition! Affiliate Disclaimer: I'm proud to be an affiliate partner of the Institute of Integrative Nutrition. If you invest in IIN, I may receive a sweet commission at no extra cost to you.
⚠️ Warning: The Million Dollar Edit course will be closed down for good tonight at MIDNIGHT (roughly 16 hours from now).So if you're still on the fence, I'd grab your seat now, before it's too late.And remember, if you don't like it, we'll give you your money back.No questions asked.You Could Spend $50 on DoorDash…OR… 🍔The $49 to get started right now will be a fraction of what this course makes you in the long run of your editing career.You could go spend $50 on a fancy dinner, or a new outfit, or the latest new gadget...but those things fade. The $49 you could spend on this course is an investment in yourself, your business, and your future.If this information does a fraction of what I say it can do, it’ll still change your business forever and give you the advantage you’re looking for.So, you have 2 choices...invest a quick $49 in this program today and finally learn how to create videos that excite your audience into paying customers, and could help you turn $49 into $2,000....or $5,000 into $1,000,000......or, you can do nothing.And you’ll be in the exact same place you’re in right now.I’m guessing you like Option #1 better, or you wouldn’t be reading this email in the first place.Am I right?I don’t know about you...but Option #1 always leaves me off a lot happier.PRE-ORDER now and get 50% OFF - Go from $99 to $49Click Here Now to Purchase - https://geni.us/million-dollar-editAgain, this pre-order special will EXPIRE in 16 HOURS!If you’re still wondering what The Million Dollar Edit course is, how it will help you become the go-to video editor with your clients, or why you should grab it today, read the email below:Blow Your Clients Away with Your Next Editing Project… 🤩If you're currently an in-house or freelance video editor, and you're trying to further your career and wow your audience...then The Million Dollar Edit™ is exactly what you've been looking for.Whether you want to learn how to edit videos that bring in seven-figures, or simply to get your audience to watch to the very end...Then the system behind The Million Dollar Edit™ course has been perfected over the last 15 years, and is the same system that allowed me to create campaign after campaign that was able to bring in over $2,500,000 in sales.Keep The Jobs Rolling in… 📈Keep the video jobs rolling in and your clients happy…VERY happy.Like I said earlier, the line between success and failure is razor-thin. Having been there myself, I can tell you that it really all boils down to one thing...Finding the beat - the heart of the edit.Listen, if your clients are spending $50K+ on a video campaign, then are expecting you as the video editor to help double, triple or even 10X their return.And we've got a way to ensure you deliver every time.Throw That Macbook in the Trash… 💻🗑️Like I've said before...You don't need an expensive M1 MacBookYou don't need a RED CameraYou don't need a fancy film degree, andYou don't need to watch 1,000+ hours of tutorials on YouTubeWe've done all the heavy lifting for you.Being able to drive your audience into the buying process through the power of video is exactly what your clients are looking for…Which is why The Million Dollar Edit™ is here!This brand-new course will walk you through a proven step-by-step formula for video editors to produce million-dollar videos that get your audience AND your marketing team more excited than they've ever been.Get hired for that next project, become the go-to in-house video expert at your company, and be proud to say that you too have been able to create million-dollar edits.And it's ready today!Here's What You'll Learn Inside the Course… ✨The House Party DJ Method, a proven strategy that will crank up the emotional intensity.How to get my audiences excited enough to follow through and buyWhich types of editing styles you need to make my videos a slam dunkGetting your marketing team back on your side as their go-to video editorI know that we're all just ONE small tweak away from turning our dull, boring videos into multi-million dollar edits.Tap into the beat to get audience engaged to actually watch the video.That's all it takes.Like I said, The Million Dollar Edit™ is available to pre-order…FOR THE NEXT 16 HOURS.Enroll now and get a special 50% OFF - https://geni.us/million-dollar-editWhat You're About to Get… 🎁The Million Dollar Edit™ Course ($999 Value)Promo Project File ($2,999) Value)Editor's Cheat Sheet ($199 Value)The Video Strategy Checklist ($499 Value)...A Total Value of $4,696!!Quick Question for you…😀...If all this course did was finally get you just ONE video edit under your belt that got kudos from your marketing team or your clients...would it be worth it?...If all this course did was give you a better shot in the edit bay at creating a video that engaged your audience to watch to the very end...would it be worth it?...If all this course did was help you reach a new level of confidence in your editing abilities...would it be worth it?I sure hope so!So here's the deal... 🧻Pre-order The Million Dollar Edit™ and receive a special 50% OFF PLUS all the Bonuses that are going to fast-track you to becoming a Million Dollar Editor.You can get access for just $49 today.PRE-ORDER now and get 50% OFF - https://geni.us/million-dollar-editAgain, this pre-order special will EXPIRE in 16 HOURS…See you on the inside!JordanP.S. Here's the link to the checkout page AND a preview of the course library.Enroll Here for 50% OFF - https://geni.us/million-dollar-editPreview the Course Library - https://geni.us/million-dollar-courseP.S. - Did you know that you can directly reply to these emails? (All replies are privately sent to my inbox)📧 If you're a Gmail user, this newsletter may automatically get routed to your "Promotions" tab. To avoid this, just drag the newsletter to your "Primary" tab — and you'll never miss a post.100% Typo Guarantee —This message was made with love, not spellcheck. No English teachers were harmed in the making of this email. Subscribe at jordanpanderson.substack.com
People often ask how I'm so joyful all the time. So, I thought I'd share how I find, and keep, my joy in teaching!If you're like me, October was EXHAUSTING. We're looking ahead to Thanksgiving and Christmas break and thinking, "If I can just make it until then..."Does that sound familiar? If so, this episode is definitely for you!Every single day is precious, not just for ourselves, but for the little ones we teach. We don't want to just wish our time away, right?So, here are my secrets to being a joyful teacher! Psst, there's also a super exciting announcement at the end!Links in today's episode:Today's blog post
Many Auckland principals are relieved to have primary-aged students back in the classroom. Schools that reopen will take extra precautions, including masks for students year four and up. Other guidelines from the Ministry of Education will be applied as each school sees fit. Rowandale School principal Karl Vassau, and Finlayson Park School principal Shirley Maihi spoke to Guyon Espiner.
Primary Star Jerry, Primary Host Gaby, Enrique and Primary Guest Dan rant, rave, discuss and mention in passing these things: being deemed a hero, self deprecation, Guy Fawkes Day, games and the emotions/feelings/sensations they provide, do narrative/american style games versus euros provide more emotional moments and much, much more! Enjoy! Don't forget to subscribe, rate and review wherever you listen to podcasts and tell your friends about the Board Game Snobs Podcast. Enjoy! For merch: https://sirmeeple.com/collections/board-game-snobs For questions, comments or general adulation: Send voice memos to email@example.com Also contact at: https://twitter.com/boardgamesnobs https://www.instagram.com/boardgamesnobs
Dr. Rae Teixeira, a Canadian new grad optometrist, shares her personal concussion experience with us. She describes the traumatic event, the initial and residual symptoms, and what therapeutic treatments she tried in an attempt to feel like herself again. You can also listen to Episode 10 of the Four Eyes podcast, Concussion Management in Primary […] The post Four Eyes Optometry Podcast: When the Optometrist Becomes the Patient with Dr. Teixeira appeared first on Defocus Media.
Hard truths are brutal to hear when you least expect them, but some truths are necessary, especially when you want to get to the next level. In this week's live podcast, hosts Kevin Palmieri and Alan Lazaros share their five hard truths that you need to hear to get a move up with your life. Their success didn't come overnight; a lot of their growth has come from uncomfortable conversations. So make sure you listen in, reflect, and learn so you'll reach your goals and achieve next-level success.Group coaching details: https://nextleveluniverse.com/group-coaching/We love connecting with you guys! Reach out on LinkedIn, Instagram, or via emailWebsite
Live from the no panic zone—I'm Steve Gruber—I am America's Voice—God Bless America this is the Steve Gruber FIERCE AND FEARLESS – in Pursuit of the truth— Here are three big things you need to know right now— ONE— The Ice and snow man cometh—and he will be coming in a big way shortly—at least that is what we are being told—remember—snow is November is never much in lower Michigan— But… TWO— Rashida Tlaib is being targeted for a primary challenge by Shri Thanedar—Shri is for We— THREE— Gretchen Whitmer is Working with Jennifer Granholm and Joe Biden to Shut Down Line 5, Raise Energy Costs
November 11, 1918. At exactly 11 AM local time, the shooting stops. It's eerily quiet for the first time in a long time. World War I has finally come to an end today after Germany and the Allied nations signed an armistice not long before. The final battle of the war, known today as the Meuse-Argonne Offensive, saw an unexpected turn of events and a surprising victory. Today: the battle that ended the first world war. How did an inexperienced American army help turn the tides? And how did the Meuse-Argonne Offensive change the way America would fight future wars?Thank you to our guest, Professor Mitchel Yockelson, author of “Forty-Seven Days: How Pershing's Warriors Came of Age to Defeat the German Army in World War I.”Primary source letter from army doctor Stanhope Bayne-Jones can be found on the website of the Historical Collections of the US National Library of Medicine. See acast.com/privacy for privacy and opt-out information.
Audrey Perry Martin is the CEO and founder of Project Elect, a nonpartisan nonprofit focused on getting women members of the Church more involved in public service. She is a California-based election law expert with over 15 years of experience, including extensive presidential election involvement as deputy general counsel at Romney for President and FEC Counsel at John McCain 2008. Audrey has worked at the Federal Election Commission, for Congress, and at private law firms in Washington, D.C. and California. She taught election law at Brigham Young University law school and serves as the vice president for communications and California chapter chair for the Republican National Lawyers Association. Audrey received her law degree from Georgetown University Law Center and a bachelor's degree in political science and journalism from BYU. She has appeared on numerous national and international media outlets, including Fox News and NPR. Audrey grew up in Utah, is the mother of three daughters, and lives in Rockland, California. She's served in many capacities in the Church, including as Primary president, in the Young Womens presidency, and in lots of teaching callings. Rachelle Price serves on the Project Elect Board of Directors and is a small business owner and mother of five. After being unanimously appointed to her local school district board of education in 2019, she was elected in 2020 to a four year term as school board trustee and is currently serving as the vice president. In addition, Rachelle is a delegate on the California School Board Association and director on her local educational foundation. She has spent years as a community and school volunteer. Some of her favorite experiences include being part of site and district strategic planning committees and coaching her local special needs baseball team. Originally from Idaho, Rachelle holds a bachelor of science degree from BYU and resides with her husband and children in Rockland, California. She has served in many capacities in the church, but her favorite callings have been stake girls camp hike leader and ward choir director. Rachelle currently serves as the stake communication assistant director. In this podcast, Rachelle and Audrey help us understand why it is important for women to run for office and get involved in their communities. Rachelle Price Audrey Perry Martin Highlights 3:30 Project Elect is a non partisan and non-profit organization. Their mission is to help more Latter-day Saint women get elected in public service. 4:20 Reasons why women should run: They are asked to by their leaders Because their communities need them 8:15 Women can use the skills that they use in their church callings to help contribute to their communities. 11:45 Project Elect helps support, encourage, and train Latter-day Saint women to help them run for office. 16:00 How can a bishop help? 21:40 Should women who are elected also have a calling? 23:30 Community service is a great opportunity for those who have been released from a calling and still want to get involved. 25:00 How can women find somewhere to serve? Each community is different and you have to get out and find opportunities. We have to step up as individuals even when we are unsure of what to do. 28:30 Everyone is busy but you can find small ways to serve. 29:45 There are seasons in a woman's life. Some seasons you will have more time than others. Do what you can in the season that you are in. 31:30 Many are concerned about the time it will take away from their families to serve in their communities. However, you can actually include your family in what you are doing. By serving and speaking up in your community you are teaching your children to do the same. Lead by example. 36:40 We need bridge builders and peacemakers in a time of contention and drama. Latter-day Saint women know how to lead by lifting up others.
Hour 2 - Cornerback Stephon Gilmore said Wednesday that he didn't agree with how the New England Patriots handled his return from surgery on his torn quadriceps, which along with his contract was a primary factor in his departure. The Headlines: Boston principal knocked out by a student, Vaccines for kids, Big money for plow truck drivers, Dog defends family from mountain lions, Alec Baldwin shooting update. Golden Knights, Sabres come to an agreement on Jack Eichel trade See omnystudio.com/listener for privacy information.
Primary ovarian insufficiency (POI), also known as premature ovarian failure, occurs when the ovaries stop functioning as they should before the age of 40. Many confuse this condition with premature menopause as the symptoms are similar, however it is not related to menopause at all. In this episode, Dr. Jackie breaks down risk factors for POI, common symptoms, treatments available and what questions & information you should have prepared when discussing this condition with your doctor. For those under 40 experiencing irregular periods, hot flashes, irritability or infertility, this episode is a must-listen. Join over 1 million people who have taken charge of their mental health by visiting BetterHelp.com/Jackie to get 10% off your first month. Give Bonafide a try today—no hormones, no prescription required. To get 20% off your first purchse, go to Hellobonafide.com and use promo code JACKIE. Produced by Dear Media
Teacher, how are your students doing with their foundational skills?In today's episode, I'm going to share a real teacher struggle moment I had recently. The short version is my students did NOT master CVC words after I taught them with our district's curriculum. So, it was time to go back to my tried and true method: routines. Routines are incredibly powerful. With a little time every day, we can practice the most important concepts, and our students can master them.Here's how I'm doing it!Links in today's epiosde:Today's blog postPhast Phonics routineDaily Write It sentence routine